Student Venture Showcase 2025

KaraOrchee Inc.

Conduct Your Orchestra, Anywhere, Anytime Perform with a customized AI-driven Orchestra that follows your instructions. KaraOrchee invites musicians into a global community to connect, collaborate, and create, anytime and anywhere.  We are not just an app; we are revolutionizing the way the world plays and experiences classical music.

Counsel AI

CounselAI is an AI-powered eDiscovery platform that helps attorneys better scrutinize evidence and build their cases. Through our fast, intelligent, and frictionless design, CounselAI creates a "SMART" case folder to help attorneys analyze voluminous case discoveries. Using a non-generative approach, we leverage top-tier natural language processing techniques to extract discovery data from a wide range of file types, classify documents into relevant categories, and summarize critical case facts — all while protecting attorney-client privilege. We employ transparent and translatable strategies to minimize legal liability for law firms.

Corti Track

CortiTrack solves the critical problem of cortisol monitoring through a revolutionary wearable microneedle patch that combines three key innovations. At its core is an advanced electroactive molecularly imprinted polymer (E-MIP) sensing technology that achieves medical-grade detection limits of 0.5 ng/mL with high selectivity for cortisol, enabling reliable long-term monitoring with just a 3-minute response time. This sensing capability is integrated into a novel dual-layer microneedle design to sample interstitial fluid (accessible in the upper layer of the skin) continuously, while an inner, E-MIP coated electrode array provides precise measurements - all directed through microchannels to replaceable cartridges for sustained use. The system is made practical through seamless user-centric integration, with wireless transmission to a companion app that uses machine learning to translate real-time cortisol data into actionable health insights and personalized recommendations. This comprehensive solution is uniquely compelling because it combines the precision traditionally only available in laboratory testing with the convenience of wearable technology, making continuous cortisol monitoring both practical and accessible for research, clinical applications, and eventually consumer use. Unlike existing approaches that trade off accuracy for convenience or vice versa, CortiTrack delivers both - enabling the kind of continuous, precise monitoring needed to effectively manage the broad spectrum of cortisol-related health conditions.

Deepnosis AI

Deepnosis's goal is to revolutionize personalized medication management through the power of machine learning. We provide predictive tools for healthcare professionals to minimize adverse drug reactions, and offer patients customized education for safer medication use.

Fetal Therapy Technologies

Fetal Therapy is a surgical procedure done on a pregnant mother where the goal is to operate on her fetus and fix a life threatening birth defect. We are developing a novel port system alongside the Johns Hopkins Center for Fetal Therapy to address the lack of innovation in fetal therapy technologies, significantly enhancing the safety of these complex procedures.  The novelty of our device lies in its status as the first port system designed for use in the uterine environment. Working directly with the Johns Hopkins Fetal Therapy Center, we’ve created a solution that greatly reduces the rates of membrane rupture by having a smoother, less traumatic insertion process into the uterine environment, and minimizing the stress acting on the uterus during the procedure. Our port system integrates seamlessly into the current clinical workflow allowing for easy adoption by clinicians. This ensures that our solution is accessible and beneficial to as many patients as possible.

Jeff Spitz

Co-founder

1891 Angels

https://www.linkedin.com/in/jeffspitz/

Jeff Spitz is passionate about big ideas and the people behind them. He loves innovation — and especially the process of bringing clarity and momentum to ideas that matter. That mindset has shaped his career: from tackling public health challenges at the CDC, to helping healthcare startups sharpen their strategy at Sage Growth Partners, to launching new services at CVS Health, and driving growth at Wellinks, a virtual care company. Originally from Cincinnati, Jeff studied Environmental Studies at the University of Colorado and earned his MS in Healthcare Management at Johns Hopkins. He’s now Co-Founder and Partner at 1891 Angels, an investment network backing early-stage startups within the Hopkins innovation community. ​

Teddy Gresser

Director, Seed Funds

Tedco

https://www.linkedin.com/in/theodoregresser/

Teddy Gresser is the Director of Seed Funds at TEDCO. Teddy helps define strategy and leads seed team members with the dual objectives of investor returns and economic development for the state of Maryland. He provides thought leadership, develops  investment themes, structures and executes investments, and proactively manages  portfolio companies. Teddy has evaluated hundreds of early-stage technology companies and led investments across verticals ranging from Life Sciences, Cybersecurity, SaaS, FinTech, Advanced Materials, Robotics, Drones, and more.​ Teddy also brings to the table experience co-founding an angel investing syndicate focused on Climate Tech and consulting for an innovative life sciences start up in Baltimore.

Neil Davis

General Partner

TCP Venture Capital

https://www.linkedin.com/in/nrdavis/

Neil Davis has nearly 20 years of experience working with entrepreneurs and their early-stage technology-based startup companies. He also has 30+ years of experience in roles ranging from engineering to business development to new product launch to P&L management in the energy / environment space. He is currently a General Partner in the Propel III Fund of TCP Venture Capital. While at the Maryland Technology Development Corporation (TEDCO) Mr. Davis’s team developed and managed innovative, new entrepreneur support programs and, as part of TEDCO’s seed investment team, he led investments in medical device, digital health, fintech, and SaaS start-ups. While at the Emerging Technology Centers (ETC) he provided business consulting services to a wide array of early-stage technology and biotechnology companies.​

Aaron Shapiro

Investor

Strips

https://www.linkedin.com/in/ashapiro914/

Aaron Shapiro is an Investor at Stripes in New York City, NY, a global growth investor that catalyzes business scaling. Prior to this, Aaron was an Investor at Greenspring Associates in Baltimore while simultaneously Co-Founding and building his own startup, Graff Golf. Aaron earned his B.S. in Economics, Entrepreneurship and Management at Johns Hopkins University.  Graff Golf competed in the first Student Venture Showcase in 2022.​

Supriya Munshaw

Associate Professor of Practice

TCP Ventures and Johns Hopkins Carey Business School

https://www.linkedin.com/in/supriya-munshaw-370836a/

Supriya Munshaw, Associate Professor and Associate Dean for Academic Programs at Carey Business School. Her primary interest lies in commercializing early-stage technologies, especially in the life science and medical device industries. In her role as the Associate Dean, she oversees all of Carey’s Masters programs and Certificates. She is the Associate Director of the NIDA-funded Innovations for Substance Use Disorders Program, where she works with academic innovators to help them commercialize their research. Outside Carey, she is a general partner at TCP Venture Capital, which invests in early-stage companies headquartered in Baltimore, MD. She has served on NIH and USDA SBIR grant review panels and has previously served as an adjunct instructor for the NSF I-Corps program.​

Barbara White

Startup and Small Business advisor, Associate Professor of Practice

The Avoka Group and Johns Hopkins Carey Business School

https://www.linkedin.com/in/barbara-white-286233/

Barbara White has extensive experience as a strategist, advisor, and investor, working with Fortune 500 companies, U.S. Federal Agencies, and start-ups.

Over her 30-year career, she has assisted organizations, leaders, and their teams in transforming strategic ideas into practical, integrated solutions that achieve results and support their missions. As a Board Member and Investor, she focuses on supporting women and underrepresented founders.

She is the Board Vice President of Citrine Angels, an women-led angel group that invests in women and she serves as an Advisor to The 2nd Bloom Angel Network, which funds entrepreneurs launching businesses later in their careers. Barbara frequently speaks on leadership, entrepreneurship, strategy, and organizational culture.

She holds a degree from Johns Hopkins University and serves as an Entrepreneur-In-Residence at Georgetown University and an Adjunct Instructor at Johns Hopkins University, where she teaches courses in Entrepreneurship and Venture Capital.​